Target intelligence / Profile preview

GC-rich DNA at Sp1 consensus promoter sites (GC box) (GC box)

Target
GC box
Molecular classification
DNA, Promoter element, Transcription factor binding site
01

Overview

GC-rich DNA at Sp1 consensus promoter sites, commonly known as "GC boxes," are essential regulatory motifs located within the proximal promoter regions of a wide array of genes (PubMed: 10675325). These sites serve as the docking platform for the Specificity Protein 1 (Sp1) transcription factor, which plays a pivotal role in regulating housekeeping genes and those involved in cell cycle progression, apoptosis, and angiogenesis (NIH: PMC3073341). In many human cancers, including pancreatic and lung carcinomas, Sp1 is overexpressed or hyperactive, leading to the constitutive expression of oncogenic targets like VEGF and c-Myc (PubMed: 23536430). Therapeutic strategies targeting these DNA sequences involve small molecule ligands, such as Mithramycin A and its analogues, which bind to the minor groove of GC-rich DNA with high affinity. This binding sterically blocks Sp1 from accessing its consensus sites, thereby inhibiting the transcription of Sp1-dependent genes and inducing anti-tumor effects (PubMed: 21854854). Despite their potential, the widespread distribution of GC-rich sequences in the genome poses significant challenges for achieving high specificity and minimizing off-target toxicities (PubMed: 25151359). Research continues into more selective analogues, such as EC-8042, to improve the therapeutic window and reduce the systemic toxicity associated with traditional DNA-binding agents.

Other names
GC boxSp1 binding siteGC-rich promoter elementSp1 consensus sequenceDecoy oligodeoxynucleotides for Sp1
02

Mechanism of action

Small molecules bind to the minor groove of GC-rich DNA sequences, specifically the 5'-(G/C)GGGCGG(G/C)(G/C)-3' consensus motif, thereby sterically hindering the binding of the Sp1 transcription factor and inhibiting the expression of Sp1-dependent genes (PubMed: 21854854).

03

Biological functions

Gene expression regulationTranscription initiationCell cycle regulationApoptosis regulationAngiogenesis
04

Disease associations

CancerHuntington's diseaseInflammationEwing sarcoma
05

Safety considerations

HepatotoxicityNephrotoxicityThrombocytopeniaHemorrhagic diathesisOff-target DNA binding effects
06

Interacting drugs

Mithramycin A (Plicamycin)

5 more in the full profile.

07

Biomarkers

Sp1 protein levelsVEGF expressionc-Myc expressionSurvivin expression

Beyond the preview

Go deeper on GC-rich DNA at Sp1 consensus promoter sites (GC box) (GC box).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GC-rich DNA at Sp1 consensus promoter sites (GC box) (GC box).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call